Curanex Pharmaceuticals Inc Common Stock

Curanex Pharmaceuticals completed its initial public offering by having Dominari Securities fully exercise the over-allotment option, raising an additional $2.25 million and bringing total gross proceeds to $17.25 million through the issuance of 4,312,500 shares at $4.00 per share.